Intrinsic Value of S&P & Nasdaq Contact Us

Aldeyra Therapeutics, Inc. ALDX

NASDAQ Capital Marke

SharesGrow Score
60/100
3/6 Pass
SharesGrow Intrinsic Value
$414,729,000.00
+23169217777.1%
Analyst Price Target
$7.00
+291.1%

Aldeyra Therapeutics, Inc. (ALDX) current share price is $1.79. The gold spot price is $4,825.20 per troy ounce. Using the formula: ALDX in gold = $1.79 × 31.1035 ÷ $4,825.20 = 0.0115 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of ALDX when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding ALDX shares over the measured period.

ALDX in US Dollars
Gold in US Dollars
ALDX in Gold (grams per share)

Real Wealth Growth Rate

ALDX
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{ALDX}_{\text{gold}}(t) = \frac{P_{\text{ALDX}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{ALDX}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{ALDX}_{\text{gold}}^{(T)}}{\text{ALDX}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{ALDX}_\text{gold}^{(0)}$ = initial gold-price, $\text{ALDX}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

BPMC
BPMC
Blueprint Medicines Corporation
$129.46
+0.14%
IBRX
IBRX
ImmunityBio, Inc.
$7.60
+4.11%
TERN
TERN
Terns Pharmaceuticals, Inc.
$52.68
+0.13%
TVTX
TVTX
Travere Therapeutics, Inc.
$42.13
+37.23%
TARS
TARS
Tarsus Pharmaceuticals, Inc.
$73.81
+1.60%
GPCR
GPCR
Structure Therapeutics Inc.
$53.19
-1.95%
DAWN
DAWN
Day One Biopharmaceuticals, Inc.
$21.46
-0.14%
ETNB
ETNB
89bio, Inc.
$14.84
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message